FDA Warning Letter Says Beckman Coulter's Dx Analyzers 'Adulterated' or 'Misbranded'

After visiting Beckman's manufacturing facility in Brea, Calif., for three months, FDA inspectors said "methods used in, or the facilities or controls used for, their manufacture, packing, storage, or installation" do not meet GMP reqs.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.